As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

MAIA Biotechnology (MAIA) announced that the first patient has been dosed in the company’s THIO-104 Phase 3 pivotal trial evaluating the efficacy ...

Students at centers like BioTC in OKC and other locations are training to step into jobs that didn’t even exist a decade ago ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...